TKL Research, Inc.
21
0
0
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
9.5%
2 terminated/withdrawn out of 21 trials
89.5%
+2.9% vs industry average
24%
5 trials in Phase 3/4
47%
8 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System
Role: collaborator
4-Day Primary Irritation Patch Test of MIS Solution
Role: collaborator
Study to Evaluate HT-6184 in Healthy Subjects
Role: collaborator
Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence
Role: collaborator
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
Role: collaborator
A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment
Role: collaborator
Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis
Role: collaborator
A Tolerability Assessment Study of Three Wash Products in Infants
Role: collaborator
Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight
Role: collaborator
Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging
Role: collaborator
Pharmacokinetics of Voriconazole in Obese Subjects
Role: collaborator
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Role: collaborator
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
Role: collaborator
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
Role: collaborator
Topical Treatment of Under Eye Dark Circles and Swelling
Role: collaborator
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
Role: collaborator
Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects
Role: collaborator
24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
Role: collaborator
Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses
Role: collaborator
Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers
Role: lead